# Safely Quenching Complement in Stroke Survivors

> **NCT07495722** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Columbia University** · enrollment: 20 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Cerebral Infarction

## Interventions

- **DRUG:** Pegcetacoplan Injection [Empaveli]

## Key facts

- **NCT ID:** NCT07495722
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2027-04
- **Final completion:** 2027-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07495722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07495722, "Safely Quenching Complement in Stroke Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07495722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*